Business Context and Reporting Period
This Form 8-K Current Report from Reed's, Inc. (a Delaware corporation) covers events occurring on December 7, 2016, with the report filed on December 9, 2016. The filing details corporate governance changes following the company's 2016 Annual Meeting of Stockholders held on November 29, 2016.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
The primary material change reported is the reconstitution of the Board of Directors:
- Re-elected Directors: Chris Reed and Lewis Jaffe.
- New Directors: John Bello, Stefan Freeman, and Charles Cargile.
- Committee Appointments: John Bello appointed Chairman; Stefan Freeman appointed Chairman of the Compensation Committee; Charles Cargile appointed Chairman of the Audit Committee and designated as an "audit committee financial expert"; Lewis Jaffe re-appointed as Chairman of the Nominating and Governance Committee.
- Independence: All directors other than Chris Reed meet the definition of "independent director" under NYSE MKT rules.
Compensation and Governance Details
The filing outlines specific compensatory arrangements for the new directors:
- Standard Independent Director Compensation: Annual fee of $20,000 plus 30,000 stock options priced at $3.74. Vesting schedule: 10,000 immediately, 10,000 on September 30, 2017, and 10,000 on September 30, 2018. Options expire September 30, 2021.
- John Bello (Chairman) Additional Incentives: Performance-based cash incentive of $80,000 for goals achieved between November 2016 and October 2017. Additionally, 20,000 options at $3.74 with a vesting schedule of 6,666 immediately, 6,666 on September 30, 2017, and 6,667 on September 30, 2018. Options expire September 30, 2021.
The company states there are no family relationships between directors or executive officers and no other material plans or contracts between Reed's and the new directors.
Investor Verification Checklist
- Verify the stock price at the time of option grant ($3.74) against current market value to assess dilution impact.
- Confirm the independence status of the new directors against current NYSE MKT rules.
- Review the specific performance goals tied to John Bello's $80,000 cash incentive to understand potential future cash outflows.
- Check subsequent filings for the actual vesting and exercise of the granted stock options.